We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Enters into Sponsorship Agreement with NCIC CTG

News   Jun 06, 2012

 
Oncolytics Enters into Sponsorship Agreement with NCIC CTG
 
 
 

RELATED ARTICLES

3D Protein Structure Aids Anti-cancer Drug Design

News

A research team has discovered a new mechanism for a class of anti-cancer drugs known as E1 inhibitors. Their findings reveal a novel binding site that will promote drug design of more efficient E1 inhibitors.

READ MORE

Sparing Sensitive Organs from Radiation Damage to Reduce Side Effects

News

A new way to plan radiotherapy could help shape treatment away from sensitive organs near tumors to reduce side-effects, a new study shows.

READ MORE

Measuring the "Games" Cancer Cells Play

News

Researchers develop a first-in-class “game assay” which they used to directly quantify and describe the eco-evolutionary interactions between sensitive and resistant tumor cells in an experimental model of non-small cell lung cancer cells sensitive to targeted therapy.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE